Deciphera Pharmaceuticals, LLC logo

Deciphera Pharmaceuticals, LLC

18 Marks
LLC
First Filed:Nov 5, 2019Latest Filed:Jun 27, 2025Address:Building B, 200 Smith Street, Waltham, MA 02451, US

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
15(83%)
Class 44
Medical, beauty and agricultural services
6(33%)
Class 42
Software, IT Services & Scientific Research
4(22%)

TTAB Proceedings

Proceedings
1
As Plaintiff
1(100%)
As Defendant
0(0%)
Extensions of Time
2

Top Firms

Loading...

Trademark Activity Timeline(20192025)

Trademark Portfolio

18 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
MY ROMVIMZA
MY ROMVIMZA
Trademark
Combined
PENDING
Owner:
Serial:99256741
Filed:Jun 27, 2025
Classes:9
Description: Downloadable mobile application for use by patients to manage, track, and generate reports on medications, treatment compliance, health status, medical records, and appointments; downloadable mobile application for providing medical and health information to patients
DECIPHERA ACCESSPOINT
DECIPHERA ACCESSPOINT
Service Mark
Combined
PENDING
Owner:
Serial:99234759
Filed:Jun 14, 2025
Classes:35, 36, 44, +1
Description: Class 35: Provision of consumer information regarding the selection of prescription medications to be purchased for healthcare providers and patients; Provision of consumer information via a website regarding rebates, coupons, discounts, vouchers, and special offers related to prescription medications for healthcare providers and patients; Business administration of patient support programs; Providing health and prescription insurance information about medical record coding, billing, and compliance for patients and healthcare providers
Class 36: Providing health insurance information regarding healthcare insurance plans, medication insurance coverage, payor policies, reimbursement, healthcare insurance plan costs and discounts, patient financial assistance, and co-pay support programs; Administration of patient support programs in the nature of providing financial assistance for prescription medications costs; Insurance administration services in the nature of providing insurance verification, prior authorization, benefit verification, claims processing and appeal support services for prescription medications; Providing financial support, financial advice and educational financial information regarding prescription medications
Class 44: Medical services, namely, providing health information to healthcare providers and patients in connection with diseases, disease management and treatments, prescription medications, treatment protocols and recommended health information; Medical services in the nature of patient support programs for providing temporary supplies of prescription medication to eligible patients and facilitating adherence to treatment protocols and medication compliance
Class 45: Providing patient advocate and case management services, namely, coordinating the procurement, administration, adherence, and compliance of prescription medications and treatment protocols; Providing personal support services for patients with treatment adherence challenges, namely, patient advocate services in the field of medical treatment and healthcare services
ROMVIMZA
ROMVIMZA
Trademark
Combined
REGISTERED
Owner:
Serial:98817650
Filed:Oct 24, 2024
Classes:5
Registration:7934470
Registered:Sep 9, 2025
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD); Therapeutic agents, namely, kinase inhibitors
JYMLEEP
JYMLEEP
Trademark
Word
PENDING
Owner:
Serial:98322370
Filed:Dec 19, 2023
Classes:5
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
RUVYMRU
RUVYMRU
Trademark
Word
PENDING
Owner:
Serial:98322374
Filed:Dec 19, 2023
Classes:5
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
VYMRUN
VYMRUN
Trademark
Word
PENDING
Owner:
Serial:98322364
Filed:Dec 19, 2023
Classes:5
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS);; Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors.
ROMVIMZA
ROMVIMZA
Trademark
Word
REGISTERED
Owner:
Serial:98238958
Filed:Oct 25, 2023
Classes:5
Registration:8061589
Registered:Dec 9, 2025
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
ROMVYNZA
ROMVYNZA
Trademark
Word
PENDING
Owner:
Serial:98238959
Filed:Oct 25, 2023
Classes:5
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD) and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
VYNMO
VYNMO
Trademark
Word
PENDING
Owner:
Serial:98238961
Filed:Oct 25, 2023
Classes:5
Description: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
COMZURY
COMZURY
Trademark
Word
PENDING
Owner:
Serial:98166836
Filed:Sep 6, 2023
Classes:5, 42, 44
Description: Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
DUQYNZO
DUQYNZO
Trademark
Word
PENDING
Owner:
Serial:98166780
Filed:Sep 6, 2023
Classes:5, 42, 44
Description: Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
DECIPHERA
DECIPHERA
Trademark
Word
REGISTERED
Owner:
Serial:97894977
Filed:Apr 18, 2023
Classes:5, 42, 44
Registration:7380005
Registered:May 7, 2024
Description: Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER.
Owner:
Serial:90521526
Filed:Feb 9, 2021
Classes:42
Registration:6708585
Registered:Apr 19, 2022
Description: Pharmaceutical research and development | providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, autoimmune diseases and inflammatory diseases and disorders information
DECIPHERA
DECIPHERA
Trademark
Combined
REGISTERED
Owner:
Serial:90369273
Filed:Dec 9, 2020
Classes:5
Registration:6491847
Registered:Sep 21, 2021
Description: Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma | pharmaceutical research and development | medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
COMZURY
COMZURY
Trademark
Word
ABANDONED
Owner:
Serial:88866571
Filed:Apr 9, 2020
Classes:5
DUQYNZO
DUQYNZO
Trademark
Word
ABANDONED
Owner:
Serial:88846975
Filed:Mar 25, 2020
Classes:5
QINLOCK
QINLOCK
Trademark
Combined
REGISTERED
Owner:
Serial:88680329
Filed:Nov 5, 2019
Classes:5, 44
Registration:6165744
Registered:Sep 29, 2020
Description: Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
QINLOCK
QINLOCK
Trademark
Word
REGISTERED
Owner:
Serial:88680336
Filed:Nov 5, 2019
Classes:5, 44
Registration:6165745
Registered:Sep 29, 2020
Description: Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma; medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma